Table 1 Point calculation of the analyzed scores
CHA2DS2 (Point range 0–6) | CHA2DS2-VASC (Point range 0–9) | HATCH (Point range 0–7) | APPLE (Point range 0–5) | CAAP-AF (Point range 0–13) | BASE-AF2 (Point range 0–6) | MB-LATER (Point range 0–6) | |
|---|---|---|---|---|---|---|---|
Age, years | 0–1 points (≥ 75) | 0–2 points (≥ 65 and < 75, ≥ 75) | 0–1 points (≥ 75) | 0–1 points (≥ 65) | 0–3 points (< 50, ≥ 50 and < 60, ≥ 60 and < 70, > 70) | – | |
Gender | – | 0–1 points (female gender) | – | – | 0–1 points (female gender) | – | 0–1 points (male gender) |
Type of AF | – | – | – | 0–1 points (non-paroxysmal AF) | 0 or 2 points (non-paroxysmal AF) | 0–1 points (non-paroxysmal AF) | 0–1 points (non-paroxysmal AF) |
AF history duration, years | – | – | – | – | – | 0–1 points (> 6) | – |
Early recurrence (≤ 3 months after ablation) | – | – | – | – | – | 0–1 points | 0–1 points |
eGFR | – | – | – | 0–1 points (eGFR < 60 ml/min/m2) | – | – | – |
BMI, kg/m2 | – | – | – | – | – | 0–1 points (> 28) | – |
Left atrial diameter, mm | – | – | – | 0–1 points (≥ 43) | 0–4 points (< 40, ≥ 40 and < 45, ≥ 45 and < 50, ≥ 50 and < 55, ≥ 55) | 0–1 points (≥ 40) | 0–1 points (≥ 47) |
Bundle branch block | – | – | – | – | – | – | 0–1 points |
LVEF | – | – | – | 0–1 points (LVEF < 50%) | – | – | – |
Hypertension | 0–1 points | 0–1 points | 0–1 points | – | – | – | – |
Diabetes | 0–1 points | 0–1 points | – | – | – | – | – |
Coronary artery disease | – | – | – | – | 0–1 points | – | – |
Congestive heart failure history | 0–1 points | 0–1 points | 0 or 2 points | – | – | – | – |
Stroke/TIA | 0 or 2 points | 0 or 2 points | 0 or 2 points | – | – | – | – |
COPD history | – | – | 0–1 points | – | – | – | – |
Current smoking | – | – | – | – | – | 0–1 points | – |
Number of antiarrhythmics failed | – | – | – | – | 0–2 Points (0, 1–2, > 2) | – | – |